Centaurus Financial, Inc. Ionis Pharmaceuticals Inc Transaction History

Centaurus Financial, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 15, 2019	SELL	$62.09 - $86.14 $7,078 - $9,819	-114 Closed	0 $0
Q1 2019 Jul 01, 2019	SELL	$52.92 - $81.17 $68,055 - $104,384	-1,286 Reduced 91.86%	114 $1.4 Million
Q1 2019 May 13, 2019	BUY	$52.92 - $81.17 $74,088 - $113,638	1,400 New	1,400 $114,000
Q3 2018 Nov 05, 2018	SELL	$42.88 - $53.7 $60,032 - $75,180	-1,400 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$40.53 - $50.7 $56,742 - $70,980	1,400 New	1,400 $58,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.69B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.